Cure Pharmaceutical Holding Corp. Business Finance Contracts & Agreements
32 Contracts & Agreements
- Exchange Agreements (1 contract)
- Forbearance Agreements (1)
- Guaranty Agreements (1)
- Loan Agreements (1)
- Note Agreements (14)
- Purchase Agreements (4)
- Registration Rights Agreements (1)
- Release Agreements (1)
- Security Agreements (1)
- Share Agreements (1)
- Stock Agreements (2)
- Waiver Agreements (1)
- Warrant Agreements (3)
- Senior Secured Note between the Company and Ionic Ventures, LLC (Filed With SEC on December 26, 2024)
- Form of Note dated as of June 28, 2024, issued by the Company to the investor (Filed With SEC on July 5, 2024)
- Securities Purchase Agreement dated as of June 28, 2024, by and between the Company and the investor (Filed With SEC on July 5, 2024)
- Senior Secured Promissory and Security Agreement dated as of January 4, 2024, by and between the Company and the Executive (Filed With SEC on January 12, 2024)
- Guaranty, dated July 22, 2022, by and between the Company and Buyer (Filed With SEC on July 28, 2022)
- Promissory Note, dated July 22, 2022, issued by Buyer for the benefit of CURE Pharmaceutical (Filed With SEC on July 28, 2022)
- Asset Purchase Agreement, dated July 22, 2022, by and between CURE Pharmaceutical and Buyer (Filed With SEC on July 28, 2022)
- Forbearance Agreement (Filed With SEC on January 7, 2022)
- Consent and Waiver Agreement, dated February 25, 2021, by and between the Company and Ionic Ventures, LLC (Filed With SEC on February 25, 2021)
- Registration Rights Agreement (Filed With SEC on November 2, 2020)
- Secured Promissory Note (Filed With SEC on November 2, 2020)
- Note Purchase Agreement (Filed With SEC on November 2, 2020)
- Series B Convertible Note (Filed With SEC on November 2, 2020)
- Series A Convertible Note (Filed With SEC on November 2, 2020)
- Security Purchase Agreement (Filed With SEC on November 2, 2020)
- Secured Promissory Note, dated September 25, 2020, by and between CURE Pharmaceutical Holding Corp. and Ionic Ventures, LLC (Filed With SEC on September 30, 2020)
- Secured Promissory Note (Filed With SEC on July 28, 2020)
- Release, Waiver and Amendment (Filed With SEC on June 9, 2020)
- Amendment to Warrants to Purchase Common Stock (Filed With SEC on June 9, 2020)
- Specimen common stock certificate (Filed With SEC on March 30, 2020)
- Convertible Promissory Note dated November 12, 2019 (Filed With SEC on November 14, 2019)
- Convertible Demand Note Issued by Cure Pharmaceutical Holding Corp. to Chemistry Holdings, Inc (Filed With SEC on April 1, 2019)
- Securities Purchase Agreement dated December 14, 2018 (Filed With SEC on January 7, 2019)
- Form of Securities Purchase Agreement, by and between the Company and the Investors, with the form of Note (Filed With SEC on October 18, 2018)
- Form of Warrant, dated March 20, 2018 (Filed With SEC on March 26, 2018)
- Form of 9% Convertible Promissory Note, dated March 20, 2018 (Filed With SEC on March 26, 2018)
- Form of Securities Purchase Agreement between CURE Pharmaceutical Holding Corp. and various investors for up to $5,000 in convertible promissory notes, dated March 20, 2018 (Filed With SEC on March 26, 2018)
- Form of Warrant, dated December 6, 2016 (Filed With SEC on December 14, 2016)
- Form of Warrant, dated November 7, 2016 (Filed With SEC on November 15, 2016)
- Form of Share Cancellation Agreement, dated November 7, 2016 (Filed With SEC on November 15, 2016)
- Share Exchange and Conversion Agreement, dated November 7, 2016 (Filed With SEC on November 15, 2016)
- LOAN AGREEMENT (Filed With SEC on June 10, 2015)
